Depression in Parkinson's disease
https://doi.org/10.14412/2074-2711-2010-110
Abstract
About the Author
M. R. Nodel'Russian Federation
References
1. <div><p>Яхно Н.Н., Захаров В.В., Нодель М.Р. Когнитивные и другие нервно-психические нарушения при болезни Паркинсона. В кн.: Болезни движений: медицинские и социальные аспекты. Под ред. Е.И. Гусева, А.Б. Гехт. М., 2010;с.95-7.</p><p>Нодель М.Р., Яхно Н.Н. Нервно-психические нарушения при болезни Паркинсона. Неврол нейропсихиатр психосом 2009;2:3-8.</p><p>Aarsland D., Marsh L., Schrag A. Neuropsychiatric symptoms in Parkinsons Disease. Mov Dis 2009;24(15):2175-86.</p><p>Goetz C.G. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinsons Disease. Mov Dis 2010;25:104-9.</p><p>O'Sullivan S.S., Williams D.R., Gallarher D.A. et al. Non motor symptoms as presenting complaints in Parkinsons disease: a clinicopathological study. Mov Dis 2008;23:101-6.</p><p>Вознесенская Т.Г. Некогнитивные нервно-психические нарушения при когнитивных нарушениях в пожилом возрасте. Неврол журн 2010;3:4-18.</p><p>Мирецкая А.В., Федорова Н.В., Макаров В.В. Депрессивные расстройства у больных болезнью Паркинсона. Болезнь Паркинсона и расстройства движений. Рук-во для врачей (по материалам I Национального конгресса). М., 22-23 сентября 2008;97-9.</p><p>Shrag A., Jahanshahi M., Quinn N.P. What contributes to quality life in patients with Parkinsons disease? J Neurol Neurosurg Neuropsych 2000;69:308-12.</p><p>Scaravilli T., Gasparoli E., Rinaldi F. et.al. Health related quality of life in Parkinsons disease. J Neurol Neurosurg Psychiat 2003;74(2):163-9.</p><p>Mc Kinlay A., Grace R.C., Dalrymple-Alford J.C. et al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinsons disease. Park Relat Dis 2008;14:37-42.</p><p>Cole S.A., Woodard J.L., Juncos J.L. et al. Depression and disability in Parkinsons disease. J Neuropsychiatry Clin Neurosci 1996;8:20-5.</p><p>Shrag A., Jahanshahi M., Quinn N.P. What contributes to depression in Parkinsons disease? Psychol Med 2001;31:65-73.</p><p>Starkstein S.E., Preziosi T.J., Robinson R.G. Sleep disorders, pain and Parkinsons disease depression in Parkinsons disease. Eur Neurol 1991;31(6):352-5.</p><p>Norman S., Troster A.I., Fields J.A. et al. Effects of depression and Parkinsons disease on cognitive functioning. J Neuropsychiatr Clin Neurosci 2002;14(1):31-6.</p><p>Dooneief G., Mirabello E., Bell K. et al. An estimate of the incidence of depression in idiopathic Parkinsons disease. Arch Neurol 1992;49(3):305-7.</p><p>Lemke M.R. Depressive symptoms in Parkinsons disease. Eur J Neurol 2008;15(Suppl. 1):21-5.</p><p>Gotham A.M., Brown R.C., Marsden C.D. Depression in Parkinsons disease: a quantitative and qualitative analysis in Parkinsons disease. J Neuropsychiatry Clin Neurosci 1996;8:20-5.</p><p>Mayberg H.S., Starkstein S.E., Sadzot B. et al. Selective hypometaboloism in the inferior frontal lobe in depressed patients with Parkinsons Disease. Ann Neurol 1990;28(1):57-64.</p><p>Matsiu H., Nishinaka K., Oda M. et al. Depression in Parkinsons disease:diffusion tensor imaging study. J Neurol 2007;254:1170-3.</p><p>Malhi G.S., Berk M. Does dopamine dysfunction drive depression? Acta Psychiatr Scand Suppl 2007;433:116-24.</p><p>Chaudhuri K.R., Schapira A.H.V. Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-74.</p><p>Braak H., Del Tredici K., Rub U. et al. Staging of brain pathology related to sporadic Parkinsons disease. Neurology Aging 2003;24:197-210.</p><p>Mayeux R., Stern Y., Cote I. et al. Altered serotonin metabolism in depressed patients with Parkinsons Disease. Neurol 1984;34(5):642-6.</p><p>Yamomoto M. Depression in Parkinsons Disease: its prevalence, diagnosis, and neurochemical background. J Neurol 2001;248(Suppl. 3):5-11.</p><p>Kuhn W., Muller T., Gerlach M. et al. Depression in Parkinsons Disease: biogenic amines in CSF of de novo patients. J Neural Transm 1996;103(12):1441-5.</p><p>Frisina P.G., Haroutunian V., Libow L.S. The neuropathological basis for depression in Parkinsons Disease. Park Relat Dis 2009;15:144-8.</p><p>Remy P., Doder M. Lees A. et al. Depression in Parkinsons Disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-22.</p><p>Guttman M., Torti M., Warsh J. et al. Are brain serotonin transporter levels decreased in depressed patients with Parkinsons Disease? J Neurol Sci 2006;248:99.</p><p>Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotoninergic regulation of dopamine neurotransmission. Pharmacol Ther 2007;113:296-320.</p><p>Santamaria J., Tolosa E., Valles A. Parkinsons disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130-3.</p><p>Leentjens A.F., Lousberg R., Verhey F.R. Markers for depression in Parkinsons Disease. Acta Psych Scand 2002;106(3):196-201.</p><p>Cummings J.L. Depression and Parkinsons disease: a review. Am J Psychiatry 1992;149:443-54.</p><p>Tanberg E., Larsen J.P., Aarsland D. et al. Risk factors for depression in Parkinsons Disease. Arch Neurol 1997;54(5):625-30.</p><p>Rojo A., Agullar M., Garolera M.T. et al. Depression and Parkinsons disease: clinical correlates and outcome. Park Relat Dis 2003;10(1):23-8.</p><p>Cole S.A., Woodard J.L., Juncos J.L. et al. Depression and disability in Parkinsons disease. J Neuropsychiatry Clin Neurosci 1996;8(1):20-5.</p><p>Arabia G., Grossardt B.R., Geda Y.E. et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinsons disease. Arch Gen Psych 2007;64:1385-92.</p><p>Янакаева Т.А. Сравнительный анализ когнитивных и аффективных расстройств при дисциркуляторной энцефалопатии, болезни Паркинсона и болезни Альцгеймера. Дис. ... канд. мед. наук. М., 1999.</p><p>Starkstein S.E., Petracca G., Chemerinski E. et al. Depression in classic versus akinetic-rigid Parkinsons disease. J Neur Ment Dis 1998;13(1):29-33</p><p>Смоленцева И.Г., Левин О.С., Иванов А.Ю. Немоторные флюктуации при болезни Паркинсона. Болезнь Паркинсона и расстройства движений. Рук-во для врачей (по материалам I Национального конгресса). М., 22-23 сентября 2008;108-11.</p><p>Liebermann F. Depression in Parkinsons Disease - a review. Acta Neurol Scand 2006;113:1-8.</p><p>Lemke M.R. Depressive symptoms in Parkinsons disease. Eur J Neurol 2008;15(Suppl. 1):21-5.</p><p>American Psychiatric Association. Diagnostic and Statistical Manual of mental Disorders, 4th ed. Washington, DC: APA Press, 2000.</p><p>Starkstein S.E., Merello M., Jorge R. et al. A validity study of depressive syndromes in Parkinsons disease. Mov Dis 2008;23:538-46.</p><p>Inoue T., Kitagawa M., Tanaka T. et al. Depression and major depressive disorder in patients with Parkinsons disease. Mov Dis 2010;25(1):44-9.</p><p>Barone P., Antonini A., Colosimo C. et al. The PRIAMO study: a multicenter assessment of nonmotot symptoms and their impact on quality of life in Parkinson disease. Mov Dis 2009;9:215-6.</p><p>Shrag A., Barone P., Brown R.G. et al. Depression rating scales in Parkinson disease: critique and recommendations. Mov Dis 2007;22:1077-192.</p><p>Starkstein S.E., Mayberg H.S., Preziosi T.J. et al. Reliability, validity, and clinical correlates of apathy in Parkinsons disease. J Neuropsychiatry Clin Neurosci 1992;4:134-7.</p><p>Dujardin K., Sockeel P., Devos D. et al. Characteristic of apathy in Parkinsons disease. Mov Dis 2007;22:778-84.</p><p>Pedersen K.F., Larsen J.P., Alves G. et al. Prevalence and clinical correlates of apathy in Parkinsons disease: a community-based study. Park Relat Dis 2009;15:295-9.</p><p>Hilten J.J., van Hoogland G., Velde E.A. Diurnal effects of motor activity and fatigue in Parkinsons disease. J Neurol Neurosurg Psychiatr 1993;56:874-7.</p><p>Weintraub D., Morales K.H., Moberg P.J. et al. Antidepressant studies in Parkinsons disease: a review and meta-analysis. Mov Dis 2005;20:1161-9.</p><p>Miyasaki J.M., Shannon K., Voon V. et al. Practice parameter: evaluation and treatment of depression, psychosis and dementia in Parkinsons disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurol 2006;66:996-1002.</p><p>Devos D., Dujardin K., Poirot I. et al. Comparison of desipramine and citalopram treatments with depression in Parkinsons disease: a double-blind placebo-controlled study. Mov Dis 2008;23:850-7.</p><p>Menza M., Dobkin R.D., Marin H. et al. A controlled trial of antidepressants in patients with and depression. Neurol 2009;72:886-92.</p><p>Lemke M.R., Raethjen J. Depression and Parkinson disease-pathophysiology, diagnosis, treatment. Ed. Lemke M.R. Bremen: UNI-MED, 2007;70.</p><p>Mann J.J., Kapur S. A dopaminergic hypothesis of major depression. Clin Neuropharmacol 1996;18(Suppl. 1):57-65.</p><p>Barbeu A.L. L-Dopa therapy in Parkinson disease: a critical review of nine years experience. J Can Med Assoc 1969;101:791-800.</p><p>Barone P., Poewe W., Tolosa E. et al. Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinsons disease. Abstracts of the Movement Disorders Societys Thirteenth International Congress of Parkinson's disease and movement disorders 2009 June 7-11 (Suppl. 1):291.</p><p>Нодель М.Р., Артемьев Д.В., Яхно Н.Н. Эффективность дофаминового агониста Мирапекса при болезни Паркинсона. Неврол журн 1999;6:45-9.</p><p>Lemke M.P., Brecht H.M., Koester J.K. et al. Anhedonia, depression, and motor functioning in Parkinsons disease during treatment with Pramipexole. J Neuropsych Clin Neurosci 2005;17(2):214-20.</p><p>Schoenfeld M.A., Pantelie C.M., Schwartz B. Clinical criteria for the switch of treatment strategies in Parkinson's disease. Clinical Neurol and Neurosurg 2003;105:241-4.</p></div><br />